Surgical Science Sweden AB (publ) (LON:0AAU)

LON:0AAU Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	131.65	233.97	187.97	86.25	15.61
Depreciation & Amortization	41.36	38.4	35.66	23.9	10.25
Other Amortization	19.15	17.21	15.93	9.62	6.73
Other Operating Activities	10.95	-45.64	-44.46	-34	-3.52
Change in Accounts Receivable	-20.24	31.91	-70.76	-84.57	1.86
Change in Inventory	-11.56	-19.57	-21.72	6.46	-5.27
Change in Other Net Operating Assets	-34.09	-17.99	26.87	31.43	-2.43
Operating Cash Flow	137.23	238.29	129.49	39.08	23.23
Operating Cash Flow Growth	-42.41%	84.03%	231.31%	68.28%	-57.93%
Capital Expenditures	-6.1	-10.46	-9.35	-3.87	-0.4
Cash Acquisitions	-	-	-	-2,718	-
Sale (Purchase) of Intangibles	-41.43	-33.67	-25.2	-10.51	-8.3
Investing Cash Flow	-47.53	-44.13	-34.55	-2,733	-8.69
Long-Term Debt Issued	-	-	17.09	-	-
Long-Term Debt Repaid	-7.76	-3.3	-	-31.72	-5.14
Total Debt Repaid	-7.76	-3.3	-	-31.72	-5.14
Net Debt Issued (Repaid)	-7.76	-3.3	17.09	-31.72	-5.14
Issuance of Common Stock	-	-	-	3,039	7.86
Other Financing Activities	235.41	19.15	-	-84.87	1.49
Financing Cash Flow	227.65	15.85	17.09	2,922	4.21
Foreign Exchange Rate Adjustments	16.44	-9.38	5.02	0.59	-0.8
Net Cash Flow	333.79	200.63	117.05	229.52	17.94
Free Cash Flow	131.12	227.84	120.14	35.21	22.83
Free Cash Flow Growth	-42.45%	89.65%	241.18%	54.26%	-58.41%
Free Cash Flow Margin	14.83%	25.81%	14.97%	9.60%	21.78%
Free Cash Flow Per Share	2.57	4.47	2.36	0.82	0.66
Cash Income Tax Paid	27.69	14.55	8.48	3.43	9.07
Levered Free Cash Flow	279.47	94.14	95.86	17.79	10.32
Unlevered Free Cash Flow	279.94	94.55	96.19	18.11	10.65
Change in Net Working Capital	-176.76	35.16	18.88	52.89	10.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.